NovoCure Limited
NVCR
$11.09
-$0.59-5.05%
NASDAQ
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
12/1/2025
-
Simply Wall St
12/1/2025
-
GuruFocus
12/1/2025
-
GuruFocus
12/1/2025
-
TipRanks Financial Blog
12/1/2025
-
The Fly
12/1/2025
-
Business Wire
11/27/2025
-
Fool.com Headlines
11/26/2025
-
GuruFocus
11/26/2025
-
Business Wire
11/26/2025
-
MarketBeat
11/24/2025
-
TheStreet.com
11/22/2025
-
Tickeron - Stocks
11/19/2025
-
Tickeron - Stocks
11/18/2025
-
Tickeron - Stocks
11/16/2025
-
MarketBeat
11/16/2025
-
MarketBeat
11/14/2025
-
Tickeron - Stocks
11/13/2025
-
Tickeron - Stocks
11/12/2025
-
Simply Wall St
11/12/2025
-
GuruFocus
11/12/2025
-
Business Wire
Connor Clark & Lunn Investment Management Ltd. Has $10.87 Million Position in NovoCure Limited $NVCR
11/12/2025
-
MarketBeat
11/12/2025
-
Tickeron - Stocks
11/12/2025
-
Tickeron - Stocks
11/11/2025
-
Tickeron - Stocks
Income Statement
Total Revenue (TTM)
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Thursday, October 30, 2025
Period Date
Tuesday, September 30, 2025
Next Filing
Week of Feb 23 and 27 (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
Address
Neuhofstrasse 21
Baar, 6340
Baar, 6340
Country
Year Founded
Business Description
Sector
--
Industry
--
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the...
more